We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

bioMérieux and Hitachi Partnership to Focus on Microbiology and Molecular Diagnostics

By HospiMedica staff writers
Posted on 25 Mar 2008
bioMerieux (Marcy l'Etoile, France), an in-vitro diagnostics company, and Hitachi High-Technologies Corp.(Tokyo, Japan) have entered into a long-term strategic partnership. They plan to identify and develop new microbiology and molecular diagnostic systems.

New instruments developed under the partnership will be manufactured by Hitachi High-Technologies and distributed through bioMérieux's worldwide commercial network. bioMérieux is present in more than 150 countries through 38 subsidiaries and a large network of distributors. Teams from bioMérieux and Hitachi High-Technologies are working together toward development milestones on a new system.

"bioMérieux's vision, and a key objective of our 2012 strategy, is to bring full automation to microbiology laboratories around the world. This partnership enables bioMérieux to work with extremely talented engineers from Hitachi High-Technologies Corporation to better serve our customers,” said Stéphane Bancel, CEO of bioMérieux. "We will also introduce innovative systems to molecular diagnostics, leveraging bioMérieux's expertise in biology and Hitachi High-Technologies Corporation's remarkable engineering capabilities,” he added.


Related Links:
bioMerieux
Hitachi High-Technologies Corporation

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Fetal and Maternal Monitor
F9 Series
New
Digital Radiographic System
OMNERA 300M

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024